These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 11278457

  • 1. A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization.
    Egelund R, Einholm AP, Pedersen KE, Nielsen RW, Christensen A, Deinum J, Andreasen PA.
    J Biol Chem; 2001 Apr 20; 276(16):13077-86. PubMed ID: 11278457
    [Abstract] [Full Text] [Related]

  • 2. Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility.
    Egelund R, Schousboe SL, Sottrup-Jensen L, Rodenburg KW, Andreasen PA.
    Eur J Biochem; 1997 Sep 15; 248(3):775-85. PubMed ID: 9342229
    [Abstract] [Full Text] [Related]

  • 3. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
    Rodenburg KW, Kjoller L, Petersen HH, Andreasen PA.
    Biochem J; 1998 Jan 01; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
    [Abstract] [Full Text] [Related]

  • 4. Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.
    Andersen OM, Petersen HH, Jacobsen C, Moestrup SK, Etzerodt M, Andreasen PA, Thøgersen HC.
    Biochem J; 2001 Jul 01; 357(Pt 1):289-96. PubMed ID: 11415462
    [Abstract] [Full Text] [Related]

  • 5. Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activity.
    Jankun J, Specht Z, Szkudlarek M, Greenfield R, Gaikwad B, Trifonov L, Vaugeois J, Aleem AM, Basrur V, Selman SH, Zavodszky MI, Skrzypczak-Jankun E.
    Int J Mol Med; 2006 Mar 01; 17(3):437-47. PubMed ID: 16465390
    [Abstract] [Full Text] [Related]

  • 6. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
    Kjøller L, Martensen PM, Sottrup-Jensen L, Justesen J, Rodenburg KW, Andreasen PA.
    Eur J Biochem; 1996 Oct 01; 241(1):38-46. PubMed ID: 8898886
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.
    Qureshi T, Goswami S, McClintock CS, Ramsey MT, Peterson CB.
    Protein Sci; 2016 Feb 01; 25(2):499-510. PubMed ID: 26548921
    [Abstract] [Full Text] [Related]

  • 11. Additivity in effects of vitronectin and monoclonal antibodies against alpha-helix F of plasminogen activator inhibitor-1 on its reactions with target proteinases.
    Komissarov AA, Andreasen PA, Bødker JS, Declerck PJ, Anagli JY, Shore JD.
    J Biol Chem; 2005 Jan 14; 280(2):1482-9. PubMed ID: 15516335
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases.
    Aertgeerts K, De Ranter CJ, Booth NA, Declerck PJ.
    J Struct Biol; 1997 Apr 14; 118(3):236-42. PubMed ID: 9169233
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor-1 polymers, induced by inactivating amphipathic organochemical ligands.
    Pedersen KE, Einholm AP, Christensen A, Schack L, Wind T, Kenney JM, Andreasen PA.
    Biochem J; 2003 Jun 15; 372(Pt 3):747-55. PubMed ID: 12656676
    [Abstract] [Full Text] [Related]

  • 15. The structure of a serpin-protease complex revealed by intramolecular distance measurements using donor-donor energy migration and mapping of interaction sites.
    Fa M, Bergström F, Hägglöf P, Wilczynska M, Johansson LB, Ny T.
    Structure; 2000 Apr 15; 8(4):397-405. PubMed ID: 10801484
    [Abstract] [Full Text] [Related]

  • 16. A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism.
    Shore JD, Day DE, Francis-Chmura AM, Verhamme I, Kvassman J, Lawrence DA, Ginsburg D.
    J Biol Chem; 1995 Mar 10; 270(10):5395-8. PubMed ID: 7890653
    [Abstract] [Full Text] [Related]

  • 17. Importance of the amino-acid composition of the shutter region of plasminogen activator inhibitor-1 for its transitions to latent and substrate forms.
    Hansen M, Busse MN, Andreasen PA.
    Eur J Biochem; 2001 Dec 10; 268(23):6274-83. PubMed ID: 11733024
    [Abstract] [Full Text] [Related]

  • 18. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
    Skeldal S, Larsen JV, Pedersen KE, Petersen HH, Egelund R, Christensen A, Jensen JK, Gliemann J, Andreasen PA.
    FEBS J; 2006 Nov 10; 273(22):5143-59. PubMed ID: 17042782
    [Abstract] [Full Text] [Related]

  • 19. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide.
    Xue Y, Björquist P, Inghardt T, Linschoten M, Musil D, Sjölin L, Deinum J.
    Structure; 1998 May 15; 6(5):627-36. PubMed ID: 9634700
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.